It occurs to me that you might want to send a sample of the patient serum, if still available, to the manufacturer of the panels you were using to evaluate the unexplained reactivity on the cell labeled "f negative." f antigen status is often based on the presumptive Rh genotype based on the phenotype. Perhaps that cell is actually f positive. Adsorption-elution studies could probably resolve the question of the unexplained reactivity. For sure, that's beyond the scope of the average transfusion service, but it may interest the panel manufacturer.